This plain language summary of publication, co-authored by a patient, a caregiver and a treating physician, includes the patient perspective and help patients with Duchenne muscular dystrophy and their caregivers understand the results of the Cincinnati study.
The Cincinnati study looked at data from 435 males with Duchenne muscular dystrophy who were treated at the Cincinnati Children’s Hospital Medical Center. The study was carried out to further understand the differences between using prednisone and deflazacort in males with DMD.
Read the full article here.
The original article, called ‘Real-world outcomes of long-term prednisone and deflazacort use in patients with Duchenne muscular dystrophy: experience at a single, large care center’ was also published in the Journal of Comparative Effectiveness Research and can be read here.